Gates Foundation

Activity from announced rounds

All recorded activity
Rounds participated in
8
Confirmed lead rounds
0
6 roles undisclosed
New companies
8
First participation on record · 0 follow-on
Funding in participating rounds
$178.8M
6 disclosed · full round size, not this investor’s share

By stage

Undisclosed6
Series A1
Series B1

By primary sector

Biotech3
Healthtech3
AI1
Agritech1

By country

United States5
Netherlands1
Nigeria1
Sweden1

Rounds

8 in all activity
Readily Diagnostics

Readily Diagnostics develops molecular tests that help clinicians identify infectious diseases near the patient without relying on a central laboratory.

~$970KGates Foundation grant
Participant
ProFound Therapeutics

Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia

$35MStrategic
Role not disclosed
Leyden Laboratories

Develops antibody-based nasal sprays intended to prevent influenza and other respiratory-virus infections.

€40MSeries B
Role not disclosed
Kanvas Biosciences

Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy

$48MSeries A
Role not disclosed
Ten63 Therapeutics

Develops AI-driven drug discovery platform for first- and best-in-class therapeutics

$45MStrategic
Role not disclosed
Heritable Agriculture

Develops AI-driven crop improvement solutions for climate-resilient crops

$5MGrant
Role not disclosed
Qure.ai

Develops AI-powered diagnostic solutions for early detection and care management of diseases

Role not disclosed
Helium Health

Helium Health provides healthcare software, digital payment tools and financing services for African healthcare providers.

$499.9KMaternal health grant
Participant